Introduction {#S1}
============

Hematopoiesis in *Drosophila* and vertebrates is highly conserved, and there are significant similarities in the molecular mechanisms between the cardiogenic mesoderm in *Drosophila* and the aorta-gonadal-mesonephros mesoderm in mammals ([@B61]; [@B58]). *Drosophila* hemocytes are needed for immune defense, wound healing, tissue integrity and environmental stress responses. Because of the convenience of genetic manipulation, *Drosophila* are regarded as ideal models for research on the regulatory factors of hematopoiesis and the molecular mechanisms of leukemia ([@B81]; [@B16]; [@B4]).

*Drosophila* undergo two main waves of hematopoiesis ([@B35]). The first occurs in the head mesoderm at the early embryonic stage ([@B100]). The promonocytes of this stage can differentiate into mature hemocytes that contribute to populations of sessile hemocytes attached to the cuticle and circulating hemocytes in the hemolymph at the larval stage ([@B49]; [@B46]; [@B36]). The cardiogenic mesoderm of the embryo subsequently becomes a specialized organ, the lymph gland, and another hematopoietic pool is created in the larval stage ([@B86]; [@B38]). During metamorphosis, hematopoietic progenitors of the lymph gland differentiate into mature hemocytes and enter the circulation due to dispersal of the lymph gland ([@B48]; [@B29]). The hemocytes generated from these two phases can persist into the adult stage. Moreover, a recent study has revealed four clusters of hemocytes located in the dorsal part of the adult fly abdomen, termed "adult hematopoietic hubs" ([@B27]). Three types of terminally differentiated cells are generated by hematopoietic progenitors ([@B21]). Plasmatocytes are the most numerous circulating hemocytes, representing 90--95% of hemocytes in circulation, and have the ability to phagocytose invading pathogens ([@B100]; [@B21]; [@B38]). Crystal cells, so named because they contain crystalline inclusions, are other mature hemocytes ([@B86]; [@B48]) that can cause melanization reactions for wound healing ([@B79]; [@B77]). The third type of mature hemocyte is the lamellocyte; these cells are rarely found in healthy larvae ([@B48]). The main function of lamellocytes is to encapsulate foreign objects that are too large to be phagocytosed by plasmatocytes ([@B80]).

In the third larval stage, the *Drosophila* lymph gland matures and can be separated into three distinct zones: the cortical zone (CZ), the medullary zone (MZ) and the posterior signaling center (PSC) ([@B38]). Under normal conditions, the CZ consists of mature hemocytes, including plasmatocytes and crystal cells, whereas the MZ, located in the inner region of each lymph gland lobe, contains hematopoietic progenitors that can differentiate into mature hemocytes. The PSC comprises 30∼40 cells at the posterior tip of each primary lobe, acting as a hematopoietic niche ([@B59]) similar to the hematopoietic niche in the bone marrow of mammals ([@B44]), and plays a key role in regulating progenitor homeostasis (see section "The PSC Functions as a Hematopoietic Progenitor Niche"). PSC cells are distinguished by the expression of the Notch ligand Serrate (Ser), the early B-cell factor (EBF) Collier (Col) and the HOX factor Antennapedia (Antp) ([@B50]; [@B15]; [@B44]; [@B59]). Notably, wasp parasitism elevates the reactive oxygen species (ROS) level in the PSC, which is important for cellular immune responses (see section "Role of the PSC in the Cellular Immune Response to Parasitic Wasp Infection") ([@B15]; [@B90]; [@B53]).

Lymph Gland and the PSC {#S2}
=======================

Ontogeny and Terminal Differentiation of the Lymph Gland {#S2.SS1}
--------------------------------------------------------

The lymph gland is an important hematopoietic and immune organ of Drosophila. Ontogenetically, the development of the lymph gland starts at the early embryonic phase, and the naïve lymph gland forms at the late embryonic phase. At that time, a cluster of Col^+^Antp^+^ cells remain at the posterior of the lymph gland in the PSC, providing a niche for hematopoietic progenitors. Afterward, the lymph gland further develops, reaching maturity at the third-instar larval stage. Finally, dispersion of cells in the lymph gland occurs at the metamorphosis stage.

At the early embryonic phase, lymph gland progenitors, cardioblast (CB) and pericardial (PC) cells, belong to a closed lineage and are located in the cardiogenic mesoderm ([Figure 1A](#F1){ref-type="fig"}). Subsequently, the cardiogenic mesoderm gives rise to a part of the dorsal thoracic mesoderm and forms the origin of the lymph gland. The T1--T3 segments of the lateral thoracic mesoderm contain three pairs of cell clusters that express the transcription factor Odd-skipped (Odd) ([@B108]; [@B59]), and these cell clusters coalesce to form the lymph gland ([Figure 1A](#F1){ref-type="fig"}; [@B58]). Mutation of either the homeobox protein Tin or the GATA factor Pnr during this stage results in a missing lymph gland; moreover, the decapentaplegic (Dpp), heartless, Notch and wingless (Wg) pathways also participate in the formation of the lymph gland ([Table 1](#T1){ref-type="table"}; [@B58]). The precursors of the PSC express Col and Antp ([@B59]), and the separate cell clusters express Col in the T2 and T3 segments ([@B15]); however, Antp^+^ cells are located only in the T3 segment ([@B59]). The cell clusters expressing either Col or Antp partially colocalize with cells expressing Odd and are progressively restricted to the posterior region before coalescing, at which point they become the PSC of the lymph gland in the larval stage. Other Odd^+^Col^--^Antp^--^ cells are precursors of hematopoietic progenitors that are triggered to mature via a dpp signal provided by the PSC at the first larval stage. These cells become the MZ or differentiate into mature hemocytes at the third larval stage ([Figure 1A](#F1){ref-type="fig"}).

###### 

Genes/pathways involved in the ontogeny of the lymph gland.

  **Gene/pathway**   **Alteration**       **Phenotype**
  ------------------ -------------------- ---------------------------------------------------------------------
  Dpp                Loss of expression   Absence of lymph gland
  Tin                Loss of expression   
  Pnr                Loss of expression   
  Hth                Loss of expression   
  Wg                 Loss of expression   
  Notch              Loss of expression   Increased numbers of lymph gland cells
  Srp                Overexpression       
  Ubx                Loss of expression   
  Asrij              Loss of expression   
  Srp                Loss of expression   Transformation of the lymph gland primordium into pericardial cells
  Ubx                Overexpression       
  Hth                Overexpression       Reduced numbers of lymph gland PSC cells

![Ontogeny of the lymph gland and the PSC. **(A)** Odd^+^ cells form three pairs of cell clusters in the T1--T3 segments; the blue arrows indicate that these clusters coalesce to form the lymph gland. The PSC (purple) is defined by Col^+^ and Antp^+^ cells in the T2 and T3 segments. The progenitors, CBs and PCs, are closed lineages located in the cardiogenic mesoderm during the early embryo stage. At the late embryo stage, the lymph gland is along the dorsal vessel (DV), and PCs are located in the posterior lobes of the lymph gland. **(B)** In third-instar larvae, the lymph gland is mature and can be separated into three zones: the CZ, the MZ and the PSC. Three types of terminal mature hemocytes, plasmatocytes (red), crystal cells (black) and lamellocytes (yellow), are found in the lymph gland (lamellocytes rarely appear under normal conditions). The magnified view of PSC cells in the dotted-line box shows the occluding junction and filopodial extensions. During the early pupal stage, MZ cells show active proliferation and differentiation, and PSC cells are spread out. Subsequently, the lymph gland dissociates and releases hemocytes into the circulation.](fcell-08-00382-g001){#F1}

Several studies have reported factors that influence lymph gland development. For example, loss of the GATA factor *serpent* (*srp*) causes the primordium to form pericardial cells but not lymph gland progenitors ([@B58]). In addition, loss of the homeodomain cofactor *homothorax* (*hth*) causes failure of the formation of lymph glands; in contrast, overexpression of *hth* causes disappearance of the PSC ([@B59]). On the other hand, loss of some genes causes lymph gland expansion. Several embryonic cell clusters express Ultrabithorax (Ubx), which can inhibit lymph gland formation. Upon loss of *Antp*, the lymph gland excessively expands into the abdominal segments at the early embryonic phase ([@B58]). Furthermore, loss of the endocytic protein *Asrij* leads to excess lymph gland lobe formation at both the early embryonic and larval stages ([Table 1](#T1){ref-type="table"}; [@B45]). These observations suggest that endosome trafficking is extremely important for lymph gland development.

During the metamorphosis stage of pupation, MZ cells actively proliferate and differentiate into terminal mature hemocytes, while PSC cells spread throughout the lymph gland ([@B29]). When the organism enters the pupal stage, the cells of the primary lobes of the lymph gland become large and transform into phagocytic cells. The lymph gland gradually dissociates, disappearing completely by 15 h after puparium formation, and releases hemocytes into the circulation ([Figure 1B](#F1){ref-type="fig"}; [@B48]; [@B29]).

PSC Cell Features {#S2.SS2}
-----------------

[@B50] found that the lymph gland contains a Ser-expressing signaling center on each primary lobe, which was defined as the PSC. Subsequently, Ser^+^ cells have also been detected in the CZ and posterior lobes of lymph glands ([@B22]). [@B15] observed that Col, the *Drosophila* ortholog of the vertebrate gene encoding EBF, contributes to the differentiation of lamellocytes during the cellular immune response to parasitization. In addition, Ser has been found to colocalize with Col at the posterior tip of the lymph gland, and the levels of Ser are dependent on those of Col ([@B15]). Surprisingly, Col^+^ cells are not unique to the PSC but are also detected in the MZ at low levels ([@B5]; [@B71]). These results have led to controversy regarding the localization of Col in the lymph gland (see section "Necessity of the PSC for Hematopoietic Progenitor Maintenance"). [@B59] showed that the PSC also expresses Antp during both the embryonic and larval stages. Moreover, the expression of Col is dependent upon that of Antp, indicating that Antp acts upstream of Col and Ser ([@B59]).

At the early embryonic stage, the PSC of the lymph gland primordium can show active proliferation ([@B59]). However, at the larval stage, PSC cells in the mature lymph gland are mitotically inactive ([@B50]; [@B59]), and the number of PSC cells is maintained within the range of 30∼40. These data suggest that a robust mechanism that maintains stable numbers of PSC cells plays a key role in lymph gland homeostasis.

In addition, extensions of filopodia have been observed on PSC cells ([Figure 1B](#F1){ref-type="fig"}). Knockdown of the EBF *col*, the GATA factor *srp*, the BAP chromatin-remodeling complex *osa*, and other important genes causes failure of filopodial extension in the PSC ([@B44]; [@B105], [@B104]); however, the detailed mechanisms have not been carefully characterized and require extensive further study. Khadilkar et al. reported the presence of occluding junctions between PSC cells. These occluding junctions establish a permeability barrier, the function of which is to regulate the communication of signals derived from the PSC to prohemocytes (hematopoietic progenitors) and to participate in the immune response ([@B40]).

Autonomous Regulation of PSC Cells {#S2.SS3}
----------------------------------

The number of PSC cells is stable at the third-instar larval stage, suggesting that autonomous or non-autonomous regulation prevents PSC cell proliferation ([Table 2](#T2){ref-type="table"}). In the 2000s, based on the initial definition of the PSC associated with the Notch ligand Ser, the Notch pathway was proposed to be a potential important regulator of the PSC. Early research published in 2004 indicated that the Col protein is required for the expression of Ser ([@B15]). However, research published in 2007 showed that the dominant-negative forms of both Ser and Notch cause the disappearance of Col-expressing cells ([@B44]). These studies indicate that there is an interdependence between Ser and Col expression in the regulation of PSC function.

###### 

Genes/pathways involved in PSC cell regulation during the L3 stage.

  **Gene/pathway**   **Cell type**     **Description**
  ------------------ ----------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  dmyc               PSC cell          Promotes proliferation of PSC cells
  Jumu               PSC cell          Regulates the number of PSC cells by promoting dmyc expression
  Wg pathway                           
  E2F                                  
  Dpp pathway        PSC cell          Regulates the number of PSC cells by inhibiting dmyc expression and acting as a putative wg inhibitor
  Rbf                PSC cell          Regulates the number of PSC cells by inhibiting E2F expression
  Bam                PSC cell          Regulates the number of PSC cells by promoting Rbf expression and inhibiting the putative E2F cooperator ElF4F
  InR pathway        PSC cell          Responds to starvation, regulates the number of PSC cells by inhibiting translation regulation factor 4EBP expression and is regulated by feedback from dmyc through bantam
  TOR pathway        PSC cell          Responds to starvation, regulates the number of PSC cells by inhibiting translation regulation factor 4EBP expression and engages in crosstalk with the InR pathway through Akt1
  bantam             PSC cell          Regulates the number of PSC cells by promoting InR pathway signaling and is regulated by feedback from dmyc
  ARF1               PSC cell          Regulates the number of PSC cells by affecting endosome trafficking through GTPase form switching to regulate PI3K activity in the InR pathway
  Jumu               Progenitor        Regulates the number of PSC cells by promoting the expression of an unknown dmyc transcription inhibitor and by promoting PSC cell clustering through an unknown mechanism
  ARF1               Mature hemocyte   Activates Asrij (as ARF1-GTP) and regulates the number of PSC cells through an unknown mechanism related to pvr
  NA9                Mature hemocyte   Promotes proliferation of mature hemocytes and regulates the number of PSC cells through an unknown mechanism related to pvr
  Slit/Robo          CT/PSC cell       Regulates the number of PSC cells by promoting Dpp pathway signaling and PSC cell clustering via modulation of DE-cad and Cdc42 activity

*Drosophila* Myc (dMyc), the ortholog of the mammalian protooncogene cMyc that encodes a transcriptional activator, regulates cellular growth and proliferation ([@B7]). Overexpression of dMyc in the PSC increases the number of PSC cells (to ∼100 cells) ([@B73]). Jumeau (Jumu) is a member of the forkhead (Fkh) transcription factor family and can bind the FKH domain of dMyc. Knockdown of *jumu* significantly decreases the number of PSC cells; in contrast, overexpression of *jumu* in the PSC significantly increases the number of PSC cells ([@B31]).

Both the Wg/Wnt and Dpp/bone morphogenetic protein (BMP) pathways are reported to be located upstream of dMyc ([@B24]). Overexpression of *wg* increases the number of PSC cells; in contrast, expression of the inactive forms of the Wg pathway receptors Fz and DFz2 significantly reduces the number of PSC cells ([@B89]). Moreover, the increase in PSC cell number caused by overexpression of *wg* can be reversed by knockdown of *dmyc* ([@B73]). Therefore, the Wg/Wnt pathway indirectly regulates the proliferation of PSC cells by affecting dMyc levels. In contrast to Wg, Dpp/BMP limits the proliferation of PSC cells. Col downregulates dMyc by enhancing Dpp signaling, and knockdown of *col* significantly increases PSC cell numbers. Therefore, Col is also a self-autonomous negative regulator of PSC cells ([@B73]). In addition, depletion of the permeability barrier through knockdown of occluding junction components increases the number of PSC cells. When there is no permeability barrier, the strength of both Dpp and Wg signaling is decreased in PSC cells; however, the decrease in Dpp signaling overrides aberrant Wg levels and elevates dMyc expression ([@B40]). These observations suggest that permeability contributes to the regulation of PSC cell numbers through Dpp and Wg signaling.

The *Drosophila* insulin/insulin-like growth factor signaling (IIS) pathway is related to metabolism, translation and protein synthesis ([@B94]; [@B99]). The target of rapamycin (TOR) pathway is another protein synthesis-regulating signaling pathway that engages in crosstalk with the IIS pathway through Akt1. Both the IIS and TOR pathways have been shown to be involved in dMyc expression and regulation, suggesting that both pathways and their related factors are candidates for autonomous regulation of PSC cells. As expected, increased IIS signaling in the PSC through activation of phosphoinositide-3 kinase (PI3K), loss of FoxO or phosphatase and tensin homolog (PTEN), and overexpression of the insulin receptor (InR) or Akt1 can induce PSC expansion ([@B6]; [@B104]). Notably, vesicle trafficking is important for signal transduction. ADP ribosylation factor 1 (ARF1) is required for coat assembly, the Golgi architecture and endosome trafficking. ARF1 balances the IIS pathway in PSC cells by partially affecting PI3K. Furthermore, ARF1 can regulate Asrij and participate in lymph gland development by switching between GDP- and GTP-binding forms. Low levels of ARF1 in the PSC can inactivate Asrij and cause complete loss of the PSC ([@B39]). In addition, Bantam miRNA regulates IIS signaling by affecting Akt1 and is activated by dMyc. Loss of *bantam* significantly reduces the number of PSC cells; however, this effect can be reversed by overexpression of *dmyc*. Moreover, the increase in PSC cell number caused by overexpression of *bantam* can be reversed by knockdown of the InR pathway ([@B47]). Therefore, dMyc is located between Bantam and the InR pathway and regulates the signaling cascade and feedback loop.

eIF4E (4E)-binding protein (4EBP), which is an inhibitor of the elF4F complex, is inhibited by the IIS pathway ([@B102], [@B104]). Furthermore, Bag of Marbles (Bam), a negative regulator of the elF4F complex, inhibits the proliferation of PSC cells ([@B102]). Retinoblastoma-family protein (Rbf), a suppressor of cell proliferation regulated by the Bam protein, can suppress the levels of E2F, one of several transcription factors that regulate dMyc levels. Accordingly, Rbf inhibits the proliferation of PSC cells ([@B101]). These results indicate that the IIS pathway may regulate dMyc through both Bantam and the regulatory relationship between the F4F complex and E2F; however, the mechanisms involved in these interactions and the regulation of PSC development need to be further investigated.

Enhancement of TOR signaling through knockdown of tuberous sclerosis complex 2 (TSC2) causes PSC expansion; in contrast, attenuation of TOR signaling through knockdown of *rictor*, *raptor*, *Tor*, *Rheb* or *S6K* reduces PSC cell numbers. In addition, 4EBP is a downstream target of both the IIS and TOR pathways; therefore, the TOR pathway regulates PSC cells by inhibiting 4EBP. Both the IIS and TOR pathways are related to nutrient status. As expected, starvation decreases IIS and TOR pathway signaling and induces loss of the PSC ([@B85], [@B84]; [@B104]). Therefore, the IIS and TOR pathways, along with their related factors and dMyc, establish a complex interdependent regulatory network. In summary, dMyc, a hub gene, can autonomously regulate the network of PSC cells, as illustrated in [Figure 2A](#F2){ref-type="fig"}.

![Regulatory network of PSC cells in the lymph gland. **(A)** PSC cells are self-autonomously regulated by several factors that lead to increases or decreases in cell number. **(B)** The proliferation and clustering of PSC cells are regulated by extrinsic factors of the CZ, MZ and DV. The solid arrows indicate positive regulation, the 'T'-shaped arrows indicate negative regulation, the dotted arrows indicate a putative regulatory relationship, the red cross indicates that the component below is disturbed, and the question marks ('?') indicate that the detailed regulatory mechanism is uncertain. CZ, cortical zone; MZ, medullary zone; CT, cardiac tube.](fcell-08-00382-g002){#F2}

Non-autonomous Regulation of PSC Cells {#S2.SS4}
--------------------------------------

In-depth study in recent years has revealed that some cells adjacent to the PSC can regulate the proliferation or clustering of PSC cells, indicating that non-autonomous regulation exists. Cardiac tube (CT) cells and the slit/Roundabout (Robo) pathway were first discovered because the PSC is located alongside the CT. Robo, the receptor of Slit, can be activated by Slit, which is derived from the CT. Activated Robo promotes Dpp pathway signaling directly and indirectly via DE-cadherin (DE-Cad), thereby negatively regulating the proliferation of PSC cells. Under normal conditions, the number of PSC cell clusters is maintained through the dual functions of DE-Cad and Cdc42. Knockdown of *Robo* in the PSC significantly increases the number of PSC cells and splits the cells into several cell clusters; knockdown of *slit* in the CT results in an identical phenotype ([@B65]), indicating the existence of communication between the CT and lymph gland ([Figure 2B](#F2){ref-type="fig"}).

Knockdown of *jumu* in MZ cells elevates dMyc levels in the PSC through an unknown mechanism, not only significantly increasing PSC cell numbers but also splitting PSC cells into several clusters. However, the DE-Cad and Cdc42 levels remain unchanged ([@B31]). In the CZ, specific knockdown of the ARF1 guanine nucleotide exchange factor (Gartenzwerg) or overexpression of a GTPase-activating protein that keeps Gartenzwerg in its inactive form results in significant loss of PSC cells ([@B39]). In addition, overexpression of NUP98-HOXA9 (NA9) causes significant expansion of PSC cells, and the candidate mechanism involves signaling mediated by platelet-derived growth factor (PDGF)/vascular endothelial growth factor (VEGF)-related receptor (Pvr) from mature hemocytes to DE-Cad in PSC cells. This observation reinforces Pvr as a regulator of PSC cell numbers and clustering. However, NA9 in the CZ cannot regulate Pvr expression directly ([@B4]). The differentiated cells of the CZ can control progenitors, which are triggered by binding of PDGF/VEGF-related factor 1 (Pvf1) of the PSC to Pvr on CZ cells ([@B63]) (see details in section "The PSC Indirectly Maintains the Homeostasis of Progenitors via Hemocyte Differentiation"). Both ARF1 and NA9 in the CZ interact with Pvr ([@B4]); however, the detailed mechanism by which Pvr regulates DE-Cad in PSC cells requires clarification ([Figure 2B](#F2){ref-type="fig"}).

The Psc Functions as a Hematopoietic Progenitor Niche {#S3}
=====================================================

Undoubtedly, the balance between hematopoietic progenitor maintenance and differentiation is very important. PSC cells, which compose a hematopoietic progenitor niche, contribute to maintaining this balance via direct and indirect maintenance of progenitor regulation. In addition, PSC cells are able to convert hematopoietic progenitor precursors into mature hematopoietic progenitors at the first larval stage. However, two studies in 2015 and 2016 sparked controversy regarding the necessity of PSC cells for the maintenance of hematopoietic progenitors in the MZ.

The PSC Directly Maintains the Homeostasis of Hematopoietic Progenitors {#S3.SS1}
-----------------------------------------------------------------------

PSC cells can secrete ligands directly into the MZ, which activates a corresponding signaling pathway related to the maintenance of hematopoietic progenitors in the activated MZ. The Hedgehog (Hh) signaling pathway is related to cell growth and differentiation ([@B54]). Hh signaling has been widely studied in the *Drosophila* lymph gland and is viewed as a major maintenance process of the hematopoietic progenitor pathway directly activated by the PSC because all PSC cells express the ligand Hh. Loss of Hh signaling promotes hematopoietic progenitor differentiation into plasmatocytes and crystal cells; in contrast, increased Hh secretion from the PSC inhibits the differentiation of lamellocytes ([@B59]). The progenitors of the MZ have two receptors: Patched (Ptc) and Smoothened (Smo) ([@B59]; [@B28]; [@B3]). In the absence of Hh, Ptc and Smo mediate Cubitus interruptus (Ci) in a repressor form (Ci^R^) via phosphorylation and degradation ([@B1]; [@B2]; [@B13]). In contrast, the PSC-secreted Hh protein can be transferred to the MZ and bind with Ptc to trigger the Hh signaling pathway in the lymph gland. Inactivation of Ptc can release the receptor Smo ([@B59]; [@B103]) and prevent Ci phosphorylation and degradation by protein kinase complexes of protein kinase A (PKA), casein kinase 1 (CK1) and glycogen synthase kinase-3 (GSK3) to maintain Ci in its activated form (Ci^A^), thereby maintaining hematopoietic progenitors ([Figure 3A](#F3){ref-type="fig"}; [@B14]; [@B75]; [@B55]; [@B113]).

![The PSC regulates the homeostasis of hematopoietic progenitors. **(A)** In first-instar larvae, the PSC regulates the conversion of Notch^+^/Dome^--^ progenitors into Dome^+^ progenitors. At the third larval stage, the PSC maintains the homeostasis of hematopoietic progenitors through direct and indirect mechanisms. **(B)** Two contradictory models with differing views on the requirement of the PSC for hematopoietic progenitor maintenance. The left model indicates that the PSC (defined by Antp^+^ cells) is redundant and that progenitors with low Col expression are sufficient for the maintenance of hematopoietic progenitors. The right model indicates that Hh-dependent (Odd^+^ Col^--^) progenitors are maintained by the PSC. Upon ablation of the PSC, the progenitors in the subset differentiate into mature hemocytes, which results in a decrease in MZ size. Other Hh-independent progenitors are kept quiescent by autonomous maintenance.](fcell-08-00382-g003){#F3}

Notably, Hh signaling is not induced until 18 h after egg hatching (AEH). This timing implies that before 18 h AEH, other signaling pathways play a role similar to that of the Hh pathway. There are no mature hemocytes in the lymph glands of early first-instar larvae (13 h AEH); only two types of hematopoietic progenitors, Notch^+^/domeless (Dome)^--^ and Notch^--^/Dome^+^ cells, exist. Recently, PSC-secreted Dpp has been suggested to potentially play a role in progenitor maintenance. Dpp is a ligand of the BMP pathway that is secreted from PSC cells and contributes to converting early progenitors (progenitor precursors) into mature progenitors. For example, Dpp promotes the conversion of Notch^+^/Dome^--^ progenitors into Dome^+^ progenitors at 30 h AEH. Then, these Dome^+^ progenitors form the MZ of the lymph gland at the third-instar larval stage. Weak Dpp secretion from PSC cells of first-instar larvae causes loss of Dome^+^ progenitors in the lymph gland at the third-instar stage ([@B20]; [Figure 3A](#F3){ref-type="fig"}). In addition, knockdown of Headcase (Hdc), the homolog of the tumor suppressor HECA, in the PSC has been shown to enhance Dpp secretion from PSC cells and inhibit lamellocyte differentiation ([@B107]).

In the second and third larval stages, the Hh and Antp proteins are specifically expressed only in the PSC ([@B59]). In general, the number of PSC cells reflects the strength of Hh signaling ([@B59]; [@B6]; [@B47]; [@B101]), and an increase in PSC cell number strongly inhibits the differentiation of progenitors caused by high levels of Hh. However, some studies have produced results inconsistent with these findings. For example, blockade of occluding junctions in the PSC has been found to promote the proliferation of PSC cells but not to increase the levels of Hh, which can promote the differentiation of progenitors ([@B40]). Col has been found to inhibit the proliferation of PSC cells; however, low levels of Col increase PSC cell numbers without inhibiting the differentiation of progenitors and decrease MZ size ([@B73]). The GATA factor Srp is a positive regulator of Hh signaling; however, knockdown of *srp* specifically in the PSC does not change PSC cell numbers ([@B105]). Similarly, PSC-specific overexpression of *Drosophila* friend of GATA transcriptional regulator, U-shaped (*ush*), a negative regulator of Hh, has no effect on PSC cell numbers.

In addition to PSC-secreted Hh and Dpp, aberrant PSC impacts the maintenance of hematopoietic progenitors signaling. The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) receptor Dome is regarded as a marker in hematopoietic progenitors of the MZ. JAK/STAT signaling maintains hematopoietic progenitors via Ush ([@B25]; [@B105]). Moreover, Ush is regulated by Smo, a receptor of the Hh pathway ([@B3]). In addition, Krzemień et al. observed that PSC cells activate JAK/STAT signaling in the MZ. Loss of Col expression induces PSC cell loss and reduces Dome^+^ cell numbers in the MZ ([@B44]; [@B73]). In summary, the PSC, JAK/STAT pathway and Ush constitute a regulatory network that controls the differentiation of hematopoietic progenitors ([Figure 3A](#F3){ref-type="fig"}). In addition, the JAK/STAT pathway in PSC cells regulates the differentiation of progenitors via an unknown mechanism. Knockdown of *hdc* induces lamellocyte differentiation, which can be reversed through knockdown of *hop*, a kinase for ligands of the JAK/STAT pathway in PSC cells ([@B107]). However, whether the JAK/STAT pathway in PSC cells contributes to the differentiation of MZ cells by affecting the JAK/STAT levels of progenitors needs to be further examined.

Wg signals also maintain hematopoietic progenitors ([@B89]). The permeability barrier consists of occluding junctions between PSC cells, which suggests that the Wg levels of PSC cells can extend to progenitors. Depletion of the permeability barrier reduces Wg signaling in both PSC cells and progenitors, thereby promoting the differentiation of progenitors ([@B40]).

Notch signaling in hematopoietic progenitors promotes the differentiation of crystal cells ([@B22]). In addition, the Notch ligand Ser is regarded as another marker of PSC cells ([@B50]; [@B111]), and loss of *ser* decreases PSC cell numbers and promotes the differentiation of progenitors ([@B44]). However, recent studies have shown that there is no relationship between the strength of the Notch signal in the PSC and that in the MZ or CZ of the lymph gland ([@B91]). Therefore, communication between the PSC and MZ through Notch signaling needs to be further defined. In 2009, ROS caused by oxidative stress were proven to promote differentiation of hematopoietic progenitors in the MZ ([@B70]). Small et al. showed that ROS in the MZ are inhibited by Notch signals of the PSC through an unknown pathway. Knockdown of the Notch signal in PSC cells causes high levels of ROS to accumulate in the MZ and numerous lamellocytes ([Figure 3A](#F3){ref-type="fig"}; [@B91]).

The PSC Indirectly Maintains the Homeostasis of Progenitors via Hemocyte Differentiation {#S3.SS2}
----------------------------------------------------------------------------------------

Pvf1 originates from the PSC and is transported into the CZ, which contains Pvr ([@B63]). Binding of Pvf1 to Pvr in the CZ results in a signaling cascade between the CZ and MZ in lymph glands. STAT92E is activated by Pvr and induces overexpression of adenosine deaminase-related growth factor A (Adgf-A). Next, Adgf-A downregulates adenosine in adjacent MZ cells, the function of which is to promote PKA to phosphorylate and degrade the key Hh signaling pathway component Ci into the active form Ci^A^ ([@B14]; [@B63]), which contributes to the maintenance of hematopoietic progenitors. This cross-region regulatory pathway, called the equilibrium signaling pathway, is analogous to the Hh signaling pathway ([Figure 3A](#F3){ref-type="fig"}; [@B63], [@B64]; [@B23]).

Necessity of the PSC for Hematopoietic Progenitor Maintenance {#S3.SS3}
-------------------------------------------------------------

The PSC has traditionally been thought to be required for the maintenance of hematopoietic progenitors. However, in 2015, Benmimoun et al. raised doubts about the previous understanding of the relationship between the MZ and PSC ([@B15]; [@B5]). These researchers found that a low level of Col expression in the MZ functioned similarly to that in the PSC by inhibiting the differentiation of hematopoietic progenitors. Furthermore, Col expression in the MZ and Col expression in the PSC were found to be independent. Antp is specifically expressed in the PSC at the third-instar larval stage. Surprisingly, neither ablation of *antp* through null mutation nor apoptosis of PSC cells driven by the proapoptotic protein Reaper (rpr) decreases the numbers of prohemocytes (cells in the MZ marked by Dome-GFP and Tep4). However, *col* null mutation promotes the differentiation of progenitors ([@B5]). A follow-up study has also confirmed that PSC cells are not required for the maintenance of progenitors. Decreasing the number of PSC cells by knocking down Wg signaling or inhibiting the Hh signaling pathway of the PSC by knocking down Srp does not induce prohemocyte differentiation ([Figure 3B](#F3){ref-type="fig"}; [@B71]). In this model, Col in MZ cells is sufficient for the maintenance of hematopoietic progenitors, and PSC cells appear redundant. Therefore, the traditional model in which the PSC functions to regulate hematopoietic progenitors has been questioned.

More recent studies have further confused the matter, leading to controversy. In 2018, Baldeosingh et al. examined the effects of specific ablation of PSC cells driven by rpr; however, their results contradicted those of the previous study. They analyzed the colocalization of Col and Odd in the MZ upon ablation of the PSC and found that the Col^--^Odd^+^ subpopulation of prohemocytes differentiated into mature hemocytes; however, other Odd^+^ prohemocytes expressing low levels of Col were maintained ([@B3]; [Figure 3B](#F3){ref-type="fig"}). [@B83] split the MZ into Hh-independent and Hh-dependent progenitors, supporting this finding. These results may be more trustworthy than the former because prohemocytes were detected with various markers, such as Odd, E-cadherin, Dome-MESO-LacZ and Ci ([@B38]; [@B111]). In addition, two studies have shown that the Hh protein derived from PSC cells is a key component that regulates hematopoietic homeostasis ([@B59]; [@B103]). The potential redundancy of the PSC in the maintenance of progenitors calls into question the functions of signaling pathways derived from the PSC. However, to date, no alternative mechanism to the signaling pathways of the PSC has been defined. In this model, hematopoietic progenitors are classified into two subpopulations: Col-low and Col-negative progenitors. However, only Col-negative progenitors are required for PSC maintenance.

In summary, studies examining the regulatory functions of PSC cells have yielded several contradictory results; therefore, this topic requires deeper investigation. Interestingly, all of the studies discussed here have consistently shown that PSC cells are required for lamellocyte differentiation in response to wasp parasitism. When the PSC is ablated, progenitors fail to differentiate into lamellocytes in response to wasp parasitism ([@B15]; [@B44]; [@B5]).

Role of the Psc in the Cellular Immune Response to Parasitic Wasp Infection {#S4}
===========================================================================

The parasitoid wasp *Leptopilina boulardi* is commonly used to infect fruit flies in order to study the cellular immune response to invasion ([@B10]). The dedicated cellular immune response promotes the proliferation of hemocytes and induces massive differentiation into lamellocytes, whose function is to encapsulate wasp eggs ([@B48]). At the end of infection, the lymph gland is disrupted and releases many lamellocytes ([@B44]). Notably, the PSC is more sensitive to wasp infection than other regions; the Toll/nuclear factor κB (NFκB) immune signaling pathway is activated in PSC cells even under normal conditions ([@B30]), suggesting that the high Toll/NFκB levels of the PSC allow this region to be constantly prepared to resist environmental infection. As described above, PSC undoubtedly plays a key role in the cellular immune response to parasitic wasps.

Wasp infection causes high levels of ROS to accumulate in the PSC, which can trigger the secretion of Spitz (s.spi), a ligand for epidermal growth factor receptor (EGFR), into the MZ, subsequently activating the EGFR signaling pathway of anterior lobe cells and causing massive lamellocyte differentiation in the lymph glands ([@B90]; [Figure 4](#F4){ref-type="fig"}). In 2017, follow-up research showed that another signaling pathway triggered by high ROS levels in PSC cells contributes to the immune response to wasp infection ([@B53]). ROS can promote cleavage of the Toll/NFκB pathway ligand Spätzle (Spz) by Spätzle-processing enzyme (SPE), therefore activating the Toll/NFκB pathway in the PSC ([@B37]). The activated NFκB pathway of the PSC induces breakdown of the permeability barrier (made of occluding junctions), which enables the immune signal to extend into the MZ ([@B40]). Next, the Toll/NF-kB pathway of the MZ is activated and promotes the differentiation of lamellocytes. Finally, high levels of Dif and Toll pathway transcription factors contribute to the dispersion of mature hemocytes from the lymph gland into the circulation. These findings suggest that the EGFR and Toll/NFκB pathways may act in parallel in response to wasp infection in PSC cells to regulate lamellocyte differentiation. However, although the EGFR and Toll/NFκB pathways have similar functions and triggering mechanisms in hematopoiesis, the relationship between the two pathways is unclear ([@B90]; [@B53]; [Figure 4](#F4){ref-type="fig"}).

![Infection with parasitic wasps or bacteria induces production of lamellocytes and disruption of the lymph gland. Parasitic wasp or bacterial infection induces a decrease in MZ size or an increase in ROS levels in the PSC, respectively, and causes activation of the EGFR and Toll pathways in the MZ. In addition, infections inhibit the JAK/STAT pathway through Lat, which overrides PSC maintenance JAK/STAT levels. These two pathways cause massive differentiation of lamellocytes. The Dif-dependent Toll/NFκB pathway contributes to the disruption of the lymph gland to release mature hemocytes into circulation.](fcell-08-00382-g004){#F4}

In addition, PSC cells maintain JAK/STAT pathway signaling in hematopoietic progenitors to inhibit prohemocyte differentiation ([@B44]; [@B25]). After wasp infection, the massive prohemocyte differentiation into mature hemocytes suggests that JAK/STAT signaling in progenitors is deactivated because PSC cells lose the capacity to maintain the JAK/STAT pathway. In addition, a short type I cytokine-related receptor, latran (lat), is activated by wasp infection. Next, activated lat in hematopoietic progenitors inhibits the JAK/STAT pathway to promote the differentiation of prohemocytes into lamellocytes ([Figure 4](#F4){ref-type="fig"}; [@B57]). This indicates that after wasp infection, inhibition of lat can override the PSC cell-mediated maintenance of the hematopoietic progenitor JAK/STAT pathway.

Psc of the *Drosophila* Lymph Gland as a Model for Investigating the Mammalian Bone Marrow Hematopoietic Stem Cell Niche {#S5}
========================================================================================================================

Similar HSC Niche Regulatory Mechanisms in *Drosophila* and Mammals {#S5.SS1}
-------------------------------------------------------------------

Mammalian hematopoietic stem cells (HSCs), which form the basis for mammalian hematopoietic processes, have the capability to produce all mature blood cell lineages. In *Drosophila*, the development of HSCs occurs in two main waves: the embryonic stage and the adult stage. During mammalian embryogenesis, HSC precursors migrate through different embryonic niches to develop into mature HSCs, which is reminiscent of the function of the *Drosophila* lymph gland PSC at the first larval stage ([@B62]; [@B20]) (see section "The PSC Directly Maintains the Homeostasis of Hematopoietic Progenitors"). In adults, the main HSCs reside in the bone marrow niche. An HSC niche can be defined as a location from which housing and maintenance regulatory signals are derived. HSC niche regulatory signals cause HSCs to remain quiescent under normal conditions and to differentiate or proliferate during immune responses ([@B97]; [@B74]).

Two types of mammalian HSC niches have been identified: the endosteal niche and the perivascular niche. HSCs are attached to osteoblasts of trabecular bone in the endosteal niche and to the fenestrated endothelia of bone marrow sinusoids in the perivascular niche ([@B109]; [@B41]; [@B12]; [@B110]). Two long-term problems in the field of mammalian HSC research are the difficulty in dissecting niches located at various anatomical sites and the lack of specific markers for identification of hematopoietic niches ([@B62]; [@B74]). Compared to mammalian niches, the PSC of the *Drosophila* lymph gland is a unique HSC niche and expresses several specific markers (see section "PSC Cell Features"). In summary, the *Drosophila* PSC is an ideal model for investigating the mammalian HSC niche regulatory mechanism.

As described above, the Hh, Dpp/BMP, wingless, Notch and Slit/Robo signaling pathways regulate hematopoietic progenitors via the PSC. Hh signaling has been conserved throughout evolution, including in mammalian HSCs ([@B26]; [@B34]). Moreover, loss of BMP receptor 1A (BMPR1A) in the mouse bone marrow stroma increases the numbers of both osteoblasts and repopulating HSCs; this effect is similar to the phenotype induced by loss of the BMP signal in the *Drosophila* PSC ([@B112]; [@B73]). Wnt in mammals is analogous to Wg in *Drosophila* ([@B87]; [@B11]; [@B72]). Overexpression of Wg in PSC cells promotes PSC cell proliferation and blocks hematopoietic progenitor differentiation ([@B89]; [@B73]), and similar observations have been made in mammals. Overexpression of Ctnnb1, a primary regulatory target of Wnt signaling, increases the HSC pool by blocking HSC differentiation ([@B42]; [@B82]). Notch also participates in developmental signaling pathways. The *Drosophila* PSC can be defined by a cell cluster expressing the Notch ligand Ser ([@B50]). Similarly, mammalian HSC niche osteoblasts express Notch1 and Notch3 and the ligands Jagged1 and Dll1 ([@B51]; [@B96]; [@B18]). In addition, the Notch pathway in both mammalian HSC niches and the *Drosophila* PSC can affect hematopoietic differentiation. However, the detailed regulatory mechanism in the mammalian HSC niche, like that in the *Drosophila* PSC, remains unclear ([@B78]; [@B91]). In *Drosophila*, Slit, secreted by the CT, binds to its receptor Robo in the PSC to activate the Slit/Robo signaling pathway ([@B65]). Similarly, slit2-Robo4 regulates HSC localization in the bone marrow perivascular niche ([@B92], [@B93]). During infection, Toll-like receptors are expressed by mammalian HSCs and can sense pathogens. Upon activation, NFκB/Toll induces HSCs to differentiate into immune cells ([@B66]; [@B114]). Analogous to the case in mammals, elevations in ROS levels in *Drosophila* PSC cells caused by pathogen infection can activate NFκB/Toll signaling in hematopoietic progenitors and promote the differentiation of plasmatocytes and lamellocytes (see section "Role of the PSC in the Cellular Immune Response to Parasitic Wasp Infection").

However, there are still some regulatory mechanisms of niche HSCs that are specific to either *Drosophila* or mammals. In mammals, loss of membrane-bound stem cell factor (SCF) decreases the numbers of osteoblasts and HSCs ([@B60]; [@B56]), and knockout of core-binding factor subunit α1 (CBFα1) causes complete loss of osteoblasts and HSCs ([@B43]; [@B69]; [@B19]). Although the *Drosophila* ortholog lozenge (lz) participates in crystal cell differentiation, there is no evidence that lz contributes to the regulation of niche HSCs ([@B21]). Constitutive activation of parathyroid hormone (PTH) or the PTH/PTH-related protein receptor (PPR) specifically in osteoblasts can increase both osteoblast and HSC populations in mouse bone marrow ([@B9]). Furthermore, Cxcl12 and its receptor Cxcr4 have been shown to contribute to niche HSC regulation ([@B116]; [@B98]; [@B106]).

*Drosophila* PSC and Leukemia {#S5.SS2}
-----------------------------

Leukemia is a kind of malignant disease whose symptoms include increased numbers of leucocytes in the blood or bone marrow. As observed in human leukemia, melanotic tumors, which are composed of aggregated hemocytes and large numbers of abnormal lamellocytes, can appear in *Drosophila* ([@B8]). Leukemic stem/progenitor cells (LSCs) or leukemia-initiating cells (LICs) are the root mediators of leukemia initiation, drug resistance and relapse ([@B115]; [@B76]). Reducing the maintenance of LSCs and LICs through niche regulatory signaling is a therapeutic strategy. The genetically conserved Hh pathway has been demonstrated to be required for leukemia-initiating cell differentiation ([@B17]; [@B52]), and *Drosophila* Hh signaling is derived from PSC cells ([@B59]). In PSC cells, Hh signaling inhibits Ush expression, and direct knockdown of Hh signaling via Hh RNAi can result in a leukemia-like phenotype ([@B59]; [@B3]). Furthermore, Hh signaling pathway inhibitors can be applied for clinical therapy of Bcr-Abl leukemia ([@B33]). Feeding of PF-04449913, an inhibitor of the human Hh pathway receptor Smo, to *Drosophila* larvae significantly promotes LSC differentiation and blocks relapse ([@B28]).

In mammals, LSCs can modulate and hijack the hematopoietic niche to outcompete normal HSCs ([@B67]; [@B74]), and similar capabilities have been observed in *Drosophila*. Notably, HOX transcription factors have been observed to be dysregulated in acute myeloid leukemia (AML). Misexpression of NA9 in mature *Drosophila* hemocytes using the UAS/Gal4 system not only promotes hemocyte proliferation and hyperplastic growth of the lymph gland but also induces PSC expansion ([@B4]). In addition, misexpression of NA9 can interfere with Pvr signaling, which is involved in leukemia ([@B95]; [@B32]). These observations suggest that proliferation of PSC cells is related to the leukemia-like phenotype.

Conclusion and Perspectives {#S6}
===========================

The *Drosophila* lymph gland is a powerful model for studying hematopoiesis, and the PSC has become an ideal model for studying niche interactions with HSCs. However, some questions about the PSC remain to be answered. For example, whether the PSC is required for the maintenance of hematopoietic progenitors or whether Col-positive progenitors are sufficient for this maintenance remains an important question. In addition, whether the number of PSC cells represents the strength of the Hh signaling pathway is unclear. Furthermore, the detailed functions of filopodial extensions of PSC cells have yet to be elucidated. Finally, although the PSC is undoubtedly the unique niche of hematopoietic progenitors in the lymph gland, hematopoietic progenitors are very rarely found among circulating hemocytes ([@B68]; [@B88]); thus, whether some cells provide a niche for circulating hematopoietic progenitors deserves to be studied.

Overall, we have summarized several important points regarding the *Drosophila* lymph gland PSC: (1) that autonomous and non-autonomous regulatory networks maintain stable numbers of PSC cells; (2) that PSC cells regulate the homeostasis of hematopoietic progenitors not only directly but also indirectly via mature hemocyte equilibrium signals; (3) that the requirement of the PSC for the maintenance of hematopoietic progenitors is currently controversial; (4) that PSC cells play a key role in the immune response via elevations in ROS levels; and (5) that the *Drosophila* lymph gland PSC can be used to investigate the relationship between leukemia and the mammalian bone marrow hematopoietic niche.
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